These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33156495)

  • 1. Imaging Early-Stage Metastases Using an
    Mason CA; Carter LM; Mandleywala K; de Souza Franca PD; Meyer JP; Mamun T; Backer JM; Backer MV; Reiner T; Lewis JS
    Mol Imaging Biol; 2021 Jun; 23(3):340-349. PubMed ID: 33156495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective Imaging of VEGFR-1 and VEGFR-2 Using 89Zr-Labeled Single-Chain VEGF Mutants.
    Meyer JP; Edwards KJ; Kozlowski P; Backer MV; Backer JM; Lewis JS
    J Nucl Med; 2016 Nov; 57(11):1811-1816. PubMed ID: 27390161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective Imaging of Vascular Endothelial Growth Factor Receptor-1 and Receptor-2 in Atherosclerotic Lesions in Diabetic and Non-diabetic ApoE
    Tekabe Y; Johnson LL; Rodriquez K; Li Q; Backer M; Backer JM
    Mol Imaging Biol; 2018 Feb; 20(1):85-93. PubMed ID: 28421362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First (18)F-labeled ligand for PET imaging of uPAR: in vivo studies in human prostate cancer xenografts.
    Persson M; Liu H; Madsen J; Cheng Z; Kjaer A
    Nucl Med Biol; 2013 Jul; 40(5):618-24. PubMed ID: 23602763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved stability of a novel fluorine-18 labeled TCO analogue for pretargeted PET imaging.
    Ruivo E; Adhikari K; Elvas F; Fissers J; Vangestel C; Staelens S; Stroobants S; Van der Veken P; Wyffels L; Augustyns K
    Nucl Med Biol; 2019; 76-77():36-42. PubMed ID: 31707309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro and In Vivo Characterization of an
    Lütje S; Franssen GM; Herrmann K; Boerman OC; Rijpkema M; Gotthardt M; Heskamp S
    J Nucl Med; 2019 Jul; 60(7):1017-1022. PubMed ID: 30655329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High in-vivo stability in preclinical and first-in-human experiments with [
    Qin X; Guo X; Liu T; Li L; Zhou N; Ma X; Meng X; Liu J; Zhu H; Jia B; Yang Z
    Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):302-313. PubMed ID: 36129493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET imaging of angiogenesis after myocardial infarction/reperfusion using a one-step labeled integrin-targeted tracer 18F-AlF-NOTA-PRGD2.
    Gao H; Lang L; Guo N; Cao F; Quan Q; Hu S; Kiesewetter DO; Niu G; Chen X
    Eur J Nucl Med Mol Imaging; 2012 Apr; 39(4):683-92. PubMed ID: 22274731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new PET tracer specific for vascular endothelial growth factor receptor 2.
    Wang H; Cai W; Chen K; Li ZB; Kashefi A; He L; Chen X
    Eur J Nucl Med Mol Imaging; 2007 Dec; 34(12):2001-10. PubMed ID: 17694307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-CEA antibody fragments labeled with [(18)F]AlF for PET imaging of CEA-expressing tumors.
    Lütje S; Franssen GM; Sharkey RM; Laverman P; Rossi EA; Goldenberg DM; Oyen WJ; Boerman OC; McBride WJ
    Bioconjug Chem; 2014 Feb; 25(2):335-41. PubMed ID: 24382090
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Gao F; Peng C; Zhuang R; Guo Z; Liu H; Huang L; Li H; Xu D; Wen X; Fang J; Zhang X
    Nucl Med Biol; 2019; 72-73():62-69. PubMed ID: 31330414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging tumor angiogenesis in breast cancer experimental lung metastasis with positron emission tomography, near-infrared fluorescence, and bioluminescence.
    Zhang Y; Hong H; Nayak TR; Valdovinos HF; Myklejord DV; Theuer CP; Barnhart TE; Cai W
    Angiogenesis; 2013 Jul; 16(3):663-74. PubMed ID: 23471463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography imaging of vascular endothelial growth factor receptor expression with (61)Cu-labeled lysine-tagged VEGF121.
    Zhang Y; Hong H; Niu G; Valdovinos HF; Orbay H; Nayak TR; Chen X; Barnhart TE; Cai W
    Mol Pharm; 2012 Dec; 9(12):3586-94. PubMed ID: 23137334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative PET imaging of VEGF receptor expression.
    Chen K; Cai W; Li ZB; Wang H; Chen X
    Mol Imaging Biol; 2009; 11(1):15-22. PubMed ID: 18784964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation,
    Barta P; Kamaraj R; Kucharova M; Novy Z; Petrik M; Bendova K; Hajduch M; Pavek P; Trejtnar F
    Bioconjug Chem; 2022 Oct; 33(10):1825-1836. PubMed ID: 36197842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-step (18)F labeling of non-peptidic bivalent integrin αvβ3 antagonist for cancer imaging.
    Wang W; Liu Z; Li Z
    Bioconjug Chem; 2015 Jan; 26(1):24-8. PubMed ID: 25551189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Efficient Method for Labeling Single Domain Antibody Fragments with
    Zhou Z; Devoogdt N; Zalutsky MR; Vaidyanathan G
    Bioconjug Chem; 2018 Dec; 29(12):4090-4103. PubMed ID: 30384599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo evaluation of a (18)F-labeled high affinity NOTA conjugated bombesin antagonist as a PET ligand for GRPR-targeted tumor imaging.
    Varasteh Z; Aberg O; Velikyan I; Lindeberg G; Sörensen J; Larhed M; Antoni G; Sandström M; Tolmachev V; Orlova A
    PLoS One; 2013; 8(12):e81932. PubMed ID: 24312607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiolabeled B9958 Derivatives for Imaging Bradykinin B1 Receptor Expression with Positron Emission Tomography: Effect of the Radiolabel-Chelator Complex on Biodistribution and Tumor Uptake.
    Zhang Z; Amouroux G; Pan J; Jenni S; Zeisler J; Zhang C; Liu Z; Perrin DM; Bénard F; Lin KS
    Mol Pharm; 2016 Aug; 13(8):2823-32. PubMed ID: 27348517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Metal-Free DOTA-Conjugated
    Roxin Á; Zhang C; Huh S; Lepage M; Zhang Z; Lin KS; Bénard F; Perrin DM
    Bioconjug Chem; 2019 Apr; 30(4):1210-1219. PubMed ID: 30896929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.